Hepatitis Monthly

Published by: Kowsar

Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran

Behnam Honarvar 1 , Kamran Bagheri Lankarani 1 , Parisa Keshani 2 , * and Tayebe Rafiee 2
Authors Information
1 Health Policy Research Centre, Institute of Health, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: April 2017, 17 (4); e12295
  • Published Online: April 16, 2017
  • Article Type: Research Article
  • Received: December 3, 2016
  • Revised: February 22, 2017
  • Accepted: April 8, 2017
  • DOI: 10.5812/hepatmon.44962

To Cite: Honarvar B, Bagheri Lankarani K, Keshani P, Rafiee T. Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran, Hepat Mon. 2017 ;17(4):e12295. doi: 10.5812/hepatmon.44962.

Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012; 10(8): 837-58[DOI][PubMed]
  • 2. Sohrabpour A, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S, Pourshams A. Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. Middle East J Dig Dis. 2010; 2(1): 14-9[PubMed]
  • 3. Fan JG, Cao HX. Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2013; 28 Suppl 4: 81-7[DOI][PubMed]
  • 4. Agrawal S, Duseja A. Nonalcoholic Fatty Liver Disease--The Clinician's Perspective. Trop Gastroenterol. 2014; 35(4): 212-21[PubMed]
  • 5. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 6. Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol. 2015; 7(3): 575-82[DOI][PubMed]
  • 7. Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann Gastroenterol. 2012; 25(1): 45-51[PubMed]
  • 8. Verdelho Machado M, Cortez-Pinto H. Fatty liver in lean patients: is it a different disease? Ann Gastroenterol. 2012; 25(1): 1-2[PubMed]
  • 9. Vos B, Moreno C, Nagy N, Fery F, Cnop M, Vereerstraeten P, et al. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastroenterol Belg. 2011; 74(3): 389-94[PubMed]
  • 10. Razavizade M, Jamali R, Arj A, Matini SM, Moraveji A, Taherkhani E. The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 11. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010; 13(5): 654-62[DOI][PubMed]
  • 12. Ashtari S, Pourhoseingholi MA, Zali MR. Non-alcohol fatty liver disease in Asia: Prevention and planning. World J Hepatol. 2015; 7(13): 1788-96[DOI][PubMed]
  • 13. Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, et al. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. Iran J Public Health. 2014; 43(9): 1275-83[PubMed]
  • 14. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med. 2013; 16(10): 584-9[PubMed]
  • 15. Wang Y, Dong J, Liu HY, Wang DQ, Tian YP. Biochemical characteristics and risk factors in non-alcoholic fatty liver. Front Biosci (Elite Ed). 2010; 2: 105-10[PubMed]
  • 16. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006; 40(8): 745-52[PubMed]
  • 17. Calzadilla Bertot L, Adams LA. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016; 17(5)[DOI][PubMed]
  • 18. Lonardo A, Bellentani S, Argo CK, Ballestri S, Byrne CD, et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig Liver Dis. 2015; 47(12): 997-1006[DOI][PubMed]
  • 19. Almobarak AO, Barakat S, Khalifa MH, Elhoweris MH, Elhassan TM, Ahmed MH. Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors? Arab J Gastroenterol. 2014; 15(1): 12-5[DOI][PubMed]
  • 20. Zaribaf F, Falahi E, Barak F, Heidari M, Keshteli AH, Yazdannik A, et al. Fish consumption is inversely associated with the metabolic syndrome. Eur J Clin Nutr. 2014; 68(4): 474-80[DOI][PubMed]
  • 21. Davari A, Roudsari AH, Houshiar-rad A, Osati S, Ghavamzadeh S, Vafaee R, et al. Can current supply figures support the nutritional recommendation of fish consumption in Iran? J Param Sci. 2013; 4(3)
  • 22. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008; 48(6): 993-9[DOI][PubMed]
  • 23. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007; 47(5): 711-7[DOI][PubMed]
  • 24. World data atlas. 2016;
  • 25. Bahreynian M, Esmaillzadeh A. Quantity and quality of carbohydrate intake in Iran: a target for nutritional intervention. Arch Iran Med. 2012; 15(10): 648-9[PubMed]
  • 26. FAOSTAT, Food balance sheets 2016. 2016;
  • 27. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012; 91(6): 319-27[DOI][PubMed]
  • 28. Joulaei H, Honarvar B, Zamiri N, Moghadami M, Lankarani KB. Introduction of a pyramidal model based on primary health care: A paradigm for management of 2009 H1N1 flu pandemic. Iran Red Crescent Med J. 2010; 2010(3): 224-30
  • 29. Honarvar B, Bagheri Lankarani K, Rostami S, Honarvar F, Akbarzadeh A, Odoomi N, et al. Knowledge and practice of people toward their rights in urban family physician program: A population‑based study in Shiraz, Southern Iran. Int J Prevent Med. 2015; (3)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader